1. Treatment of Latent Tuberculosis Infection

   • Patrick Tang
   • James Johnston

   Mycobacterial Infections (H Bach, Section Editor) Open access 22 September 2017 Pages: 371 - 379

2. Reactivation of Occult HBV Infection in Patients Cured of HCV With Direct-Acting Antivirals

   • Karen Ma
   • Susanne Shokoohi
   • Nancy Reau

   Hepatitis C (J Raybould, Section Editor) 20 September 2017 Pages: 380 - 388

   

3. Retreatment Options Following HCV Direct-Acting Antiviral Failure

   • Autumn Zuckerman
   • Cody A. Chastain
   • Susanna Naggie

   Hepatitis C (J Raybould, Section Editor) 04 November 2017 Pages: 389 - 402

4. Treating Hepatitis C Infection in Patients With Chronic Kidney Disease: Our Options Have Improved Greatly

   • Bruce A. Luxon

   Hepatitis C (J Raybould, Section Editor) 18 October 2017 Pages: 403 - 410

5. Managing the HIV/HCV-Co-Infected Patient in the Direct-Acting Antiviral Era: a Review of Pertinent Drug Interactions

   • Rebecca N. Kumar
   • Gayle P. Balba

   Hepatitis C (J Raybould, Section Editor) 08 November 2017 Pages: 411 - 424